IS2526B - Bensoxasepínafleiður og notkun þeirra sem AMPA viðtakahvatar - Google Patents

Bensoxasepínafleiður og notkun þeirra sem AMPA viðtakahvatar

Info

Publication number: IS2526B
Authority: IS; Iceland
Prior art keywords: ampa receptor; benzoxazepine derivatives; catalyst; receptor catalyst; benzoxazepine
Prior art date: 2001-06-11

Application number

IS7036A

Other languages

English (en)

Other versions

IS7036A (is

Inventor

Mingqiang Zhang

Mohammad Shahid

Simon James Anthony Grove

Original Assignee

Organon Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-11

Filing date

2003-11-13

Publication date

2009-07-15

2003-11-13 Application filed by Organon Nv filed Critical Organon Nv

2003-11-13 Publication of IS7036A publication Critical patent/IS7036A/is

2009-07-15 Publication of IS2526B publication Critical patent/IS2526B/is

Links

ZCXLTWVZYXBHJS-UHFFFAOYSA-N 1,2-benzoxazepine Chemical class O1N=CC=CC2=CC=CC=C12 ZCXLTWVZYXBHJS-UHFFFAOYSA-N 0.000 title 1
102000003678 AMPA Receptors Human genes 0.000 title 1
108090000078 AMPA Receptors Proteins 0.000 title 1
239000003054 catalyst Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D515/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Gynecology & Obstetrics (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)

IS7036A 2001-06-11 2003-11-13 Bensoxasepínafleiður og notkun þeirra sem AMPA viðtakahvatar IS2526B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01202215		2001-06-11
PCT/EP2002/006185 WO2002100865A1 (en)	2001-06-11	2002-06-05	Benzoxazepine derivatives and their use as ampa receptor stimulators

Publications (2)

Publication Number	Publication Date
IS7036A IS7036A (is)	2003-11-13
IS2526B true IS2526B (is)	2009-07-15

Family

ID=8180450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7036A IS2526B (is)	2001-06-11	2003-11-13	Bensoxasepínafleiður og notkun þeirra sem AMPA viðtakahvatar

Country Status (29)

Country	Link
US (2)	US7307073B2 (is)
EP (1)	EP1399450B1 (is)
JP (1)	JP4435561B2 (is)
KR (1)	KR100863255B1 (is)
CN (1)	CN1257908C (is)
AR (1)	AR036092A1 (is)
AT (1)	ATE389659T1 (is)
AU (1)	AU2002314144B2 (is)
BR (1)	BR0210222A (is)
CA (1)	CA2450274C (is)
CO (1)	CO5550447A2 (is)
CZ (1)	CZ300052B6 (is)
DE (1)	DE60225689T2 (is)
EC (1)	ECSP034891A (is)
ES (1)	ES2301651T3 (is)
HR (1)	HRP20031007A2 (is)
HU (1)	HUP0400154A3 (is)
IL (2)	IL158905A0 (is)
IS (1)	IS2526B (is)
MX (1)	MXPA03011563A (is)
NO (1)	NO328705B1 (is)
NZ (1)	NZ529670A (is)
PE (1)	PE20030097A1 (is)
PL (1)	PL366721A1 (is)
RU (1)	RU2279434C2 (is)
SK (1)	SK287150B6 (is)
TW (1)	TWI232863B (is)
WO (1)	WO2002100865A1 (is)
ZA (1)	ZA200309382B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1255413C (zh)	2001-06-14	2006-05-10	阿克佐诺贝尔公司	作为ampa受体正性调节剂的(吡啶并/噻吩并)－[f]－氧杂吖庚因－5－酮衍生物
US20110218190A1 (en) *	2008-11-10	2011-09-08	The Regents Of The University Of California	Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
TWI423980B (zh) *	2009-09-28	2014-01-21	Hoffmann La Roche	苯并氧氮呯ｐｉ３ｋ抑制劑化合物及使用方法
FR2964969B1 (fr) *	2010-09-16	2012-08-24	Servier Lab	Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3311842A1 (en)	2013-06-13	2018-04-25	VeroScience LLC	Compositions and methods for treating metabolic disorders
EP3436021B1 (en)	2016-03-29	2026-07-29	RespireRx Pharmaceuticals, Inc.	Compositions comprising low impact ampakines for treating attention deficit disorders
JP7113009B2 (ja)	2016-11-07	2022-08-04	アービュタスバイオファーマコーポレイション	置換ピリジノン含有三環式化合物およびそれを使用する方法
TWI801517B (zh)	2018-03-12	2023-05-11	加拿大商愛彼特生物製藥公司	經取代的2-吡啶酮三環化合物、其類似物及其使用方法
TW202010499A (zh)	2018-04-12	2020-03-16	加拿大商愛彼特生物製藥公司	經取代的吡啶酮之三環化合物的製備方法
CA3120532C (en)	2018-11-22	2023-09-26	Fujian Cosunter Pharmaceutical Co., Ltd.	Crystal form of hepatitis b surface antigen inhibitor
US20230218632A1 (en) *	2020-03-20	2023-07-13	Amathus Therapeutics, Inc.	Cyclic sulfonamide derivatives as trap1 modulators and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1238719A (is)	1968-11-01	1971-07-07
DE69331761T2 (de)	1992-07-24	2002-09-12	The Regents Of The University Of California, Oakland	Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
CN1168140A (zh)	1995-01-06	1997-12-17	弗·哈夫曼-拉罗切有限公司	羟甲基咪唑并二氮杂䓬及其酯
US5650409A (en) *	1995-06-02	1997-07-22	Cortex Pharmaceuticals, Inc.	Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) *	1996-04-03	1998-04-07	The Regents Of The University Of California	Benzoxazines for enhancing synaptic response
ES2245015T3 (es)	1997-06-09	2005-12-16	Pfizer Products Inc.	Quinazolin-4-onas como antagonistas de ampa.
US5985871A (en) *	1997-12-24	1999-11-16	Cortex Pharmaceuticals, Inc.	Benzoxazine compounds for enhancing synaptic response
RU2214405C2 (ru) *	1998-02-18	2003-10-20	НьюроСёрч А/С	Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
US6124278A (en)	1998-04-03	2000-09-26	The Regents Of The University Of California	Acylbenzoxazines for enhancing synaptic response

2002
- 2002-05-31 TW TW091111746A patent/TWI232863B/zh not_active IP Right Cessation
- 2002-06-05 JP JP2003503632A patent/JP4435561B2/ja not_active Expired - Lifetime
- 2002-06-05 IL IL15890502A patent/IL158905A0/xx unknown
- 2002-06-05 CZ CZ20033376A patent/CZ300052B6/cs not_active IP Right Cessation
- 2002-06-05 PL PL02366721A patent/PL366721A1/xx not_active IP Right Cessation
- 2002-06-05 CN CNB028116410A patent/CN1257908C/zh not_active Expired - Lifetime
- 2002-06-05 CA CA2450274A patent/CA2450274C/en not_active Expired - Lifetime
- 2002-06-05 WO PCT/EP2002/006185 patent/WO2002100865A1/en not_active Ceased
- 2002-06-05 NZ NZ529670A patent/NZ529670A/en unknown
- 2002-06-05 EP EP02740691A patent/EP1399450B1/en not_active Expired - Lifetime
- 2002-06-05 AU AU2002314144A patent/AU2002314144B2/en not_active Expired
- 2002-06-05 RU RU2004100310/04A patent/RU2279434C2/ru not_active IP Right Cessation
- 2002-06-05 DE DE60225689T patent/DE60225689T2/de not_active Expired - Lifetime
- 2002-06-05 ES ES02740691T patent/ES2301651T3/es not_active Expired - Lifetime
- 2002-06-05 AT AT02740691T patent/ATE389659T1/de active
- 2002-06-05 KR KR1020037016150A patent/KR100863255B1/ko not_active Expired - Fee Related
- 2002-06-05 BR BR0210222-6A patent/BR0210222A/pt not_active Application Discontinuation
- 2002-06-05 US US10/480,623 patent/US7307073B2/en not_active Expired - Lifetime
- 2002-06-05 SK SK1518-2003A patent/SK287150B6/sk not_active IP Right Cessation
- 2002-06-05 HU HU0400154A patent/HUP0400154A3/hu unknown
- 2002-06-05 HR HR20031007A patent/HRP20031007A2/xx not_active Application Discontinuation
- 2002-06-05 MX MXPA03011563A patent/MXPA03011563A/es active IP Right Grant
- 2002-06-10 PE PE2002000495A patent/PE20030097A1/es not_active Application Discontinuation
- 2002-06-10 AR ARP020102171A patent/AR036092A1/es unknown
2003
- 2003-11-13 IS IS7036A patent/IS2526B/is unknown
- 2003-11-17 IL IL158905A patent/IL158905A/en not_active IP Right Cessation
- 2003-12-02 ZA ZA200309382A patent/ZA200309382B/en unknown
- 2003-12-04 CO CO03107046A patent/CO5550447A2/es not_active Application Discontinuation
- 2003-12-10 NO NO20035486A patent/NO328705B1/no not_active IP Right Cessation
- 2003-12-11 EC EC2003004891A patent/ECSP034891A/es unknown
2007
- 2007-10-25 US US11/924,451 patent/US7504390B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CZ20033376A3 (en)	2004-04-14
NZ529670A (en)	2006-02-24
IL158905A (en)	2008-12-29
CO5550447A2 (es)	2005-08-31
CN1257908C (zh)	2006-05-31
CA2450274A1 (en)	2002-12-19
HUP0400154A2 (hu)	2004-07-28
JP2004533466A (ja)	2004-11-04
NO328705B1 (no)	2010-05-03
WO2002100865A1 (en)	2002-12-19
ES2301651T3 (es)	2008-07-01
ECSP034891A (es)	2004-01-28
TWI232863B (en)	2005-05-21
NO20035486D0 (no)	2003-12-10
PE20030097A1 (es)	2003-02-08
ZA200309382B (en)	2005-03-02
JP4435561B2 (ja)	2010-03-17
US7307073B2 (en)	2007-12-11
HUP0400154A3 (en)	2007-05-02
CN1514835A (zh)	2004-07-21
KR100863255B1 (ko)	2008-10-15
MXPA03011563A (es)	2004-03-18
AR036092A1 (es)	2004-08-11
US20040171605A1 (en)	2004-09-02
RU2279434C2 (ru)	2006-07-10
US7504390B2 (en)	2009-03-17
DE60225689T2 (de)	2008-07-17
AU2002314144B2 (en)	2008-01-31
HRP20031007A2 (en)	2005-10-31
US20080139529A1 (en)	2008-06-12
HK1061858A1 (en)	2004-10-08
PL366721A1 (en)	2005-02-07
IL158905A0 (en)	2004-05-12
SK287150B6 (sk)	2010-01-07
SK15182003A3 (sk)	2004-05-04
KR20040006030A (ko)	2004-01-16
EP1399450A1 (en)	2004-03-24
DE60225689D1 (de)	2008-04-30
IS7036A (is)	2003-11-13
CA2450274C (en)	2010-12-21
BR0210222A (pt)	2004-04-13
CZ300052B6 (cs)	2009-01-21
EP1399450B1 (en)	2008-03-19
ATE389659T1 (de)	2008-04-15
RU2004100310A (ru)	2005-06-10

Publication	Publication Date	Title
PT1406628E (pt)	2006-06-30	Derivados de tera-hidroquinolina
DK1427709T3 (da)	2006-04-03	3-substituerede 4-pyrimidonderivater
NO20034439L (no)	2003-12-02	Benzamidinderivater
DE60026169D1 (de)	2006-04-27	Selektive neurokinin-antagonisten
NO20042356L (no)	2004-08-12	Tioetersubstituerte imidazokinoliner
DE60222384D1 (de)	2007-10-25	Schaumerzeuger
DE60213646D1 (de)	2006-09-14	Einheitlicher absorbierender mehrschichtkern
DE60311101D1 (de)	2007-02-22	7,8,9,10-tetrahydro-6h-azepino, 6,7,8,9-tetrahydro-pyrido und 2,3-dihydro-2h-pyrrolo (2,1-b)-chinazolinon-derivate
DE60319951D1 (de)	2008-05-08	Aminocyclische substituierte pyrrolopyrimidinderivate und pyrrolopyridinderivate
DE50202516D1 (de)	2005-04-28	Gurtstraffer
DE60222723D1 (de)	2007-11-15	Gurtstraffer
DE50202369D1 (de)	2005-04-07	Gurtstraffer
IS7036A (is)	2003-11-13	Bensoxasepínafleiður og notkun þeirra sem AMPA viðtakahvatar
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
DE50113918D1 (de)	2008-06-12	Quengel-Orthese
ATE382601T1 (de)	2008-01-15	Substituierte 4-aminocyclohexanolderivate
DE50204799D1 (de)	2005-12-08	Rückenlehne
ATE299873T1 (de)	2005-08-15	Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
DE60223828D1 (de)	2008-01-10	Spermizide
DE60005282D1 (de)	2003-10-23	Golfschlägerkopf, golfschläger und golfschlägerset
DE50201746D1 (de)	2005-01-13	Prothese
DE60228736D1 (de)	2008-10-16	Menschliches bmcc1-gen
NO20014277D0 (no)	2001-09-04	Liggestol
GB0107282D0 (en)	2001-05-16	Acromial prosthesis